Posted by Michael Wonder on 20 Dec 2016
Productivity Commission’s report recommendations would hurt Australian innovation and delay access to breakthrough medicines
20 December 2016 - The Productivity Commission report recommendations, if adopted, would put local jobs, investment and Australian patients’ early access to breakthrough medicines at risk.
The Commission continues to misunderstand the value of Intellectual Property (IP) and is putting at risk the jobs of thousands of Australian scientists and medical researchers, as well as sending a signal to investors that Australia is indeed “closed for business”.
These recommendations, if implemented, would undermine the Government’s Innovation Agenda, particularly in the Medical Research sector, including local biotechnology companies.
